NeuBase Therapeutics, Inc. Acquisitions, Net of Cash Acquired
NeuBase Therapeutics, Inc. reported Acquisitions, Net of Cash Acquired of $0 for the 12-month period ending 2022-09-30, per its 10-K filed 2022-12-21.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired · last filed 2022-12-21
- NeuBase Therapeutics, Inc. payments to acquire businesses, net of cash acquired for the quarter ending 2022-09-30 was $0.00.
- NeuBase Therapeutics, Inc. payments to acquire businesses, net of cash acquired for the quarter ending 2021-09-30 was $0.00.
- NeuBase Therapeutics, Inc. payments to acquire businesses, net of cash acquired for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
- NeuBase Therapeutics, Inc. payments to acquire businesses, net of cash acquired for fiscal 2021 was $1.10M.
- NeuBase Therapeutics, Inc. payments to acquire businesses, net of cash acquired for fiscal 2020 was $0.00.
| Period end | Payments to Acquire Businesses, Net of Cash Acquired 3 month | Payments to Acquire Businesses, Net of Cash Acquired 9 month | Payments to Acquire Businesses, Net of Cash Acquired 12 month |
|---|---|---|---|
| 2022-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-12-21 | $0.00 10-K · filed 2022-12-21 | |
| 2022-06-30 | $0.00 10-Q · filed 2022-08-11 | ||
| 2021-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-12-21 | $1.10M 10-K · filed 2022-12-21 | |
| 2021-06-30 | $1.10M 10-Q · filed 2022-08-11 | ||
| 2020-09-30 | $0.00 10-K · filed 2021-12-23 |